New pill aims to keep narcolepsy patients awake and steady
NCT ID NCT07540364
First seen May 01, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This study tests a drug called samelisant in 240 adults with narcolepsy (with or without sudden muscle weakness). The goal is to see if it reduces severe daytime sleepiness and weekly episodes of cataplexy over 12 weeks. Participants will be randomly assigned to receive either samelisant or a placebo, and will complete sleepiness questionnaires and alertness tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.